Skip to main content

Peer Review reports

From: The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes

Original Submission
21 Jan 2022 Submitted Original manuscript
16 Apr 2022 Reviewed Reviewer Report
29 Apr 2022 Reviewed Reviewer Report - Mario Tiribelli
14 May 2022 Author responded Author comments - Tamara K. Moyo
Resubmission - Version 2
14 May 2022 Submitted Manuscript version 2
16 May 2022 Reviewed Reviewer Report - Mario Tiribelli
21 May 2022 Reviewed Reviewer Report
12 Aug 2022 Author responded Author comments - Tamara K. Moyo
Resubmission - Version 3
12 Aug 2022 Submitted Manuscript version 3
Publishing
9 Sep 2022 Editorially accepted
24 Sep 2022 Article published 10.1186/s12885-022-10073-w

You can find further information about peer review here.

Back to article page